Myomo Inc. (MYO) financial statements (2022 and earlier)

Company profile

Business Address 137 PORTLAND STREET
BOSTON, MA 02114
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,52412,60713,77217,37112,24113,31810,733
Cash and cash equivalents15,52412,60713,77217,37112,24113,31810,733
Receivables1,9602,2161,132765925309311
Inventory, net of allowances, customer advances and progress billings808644729794707760679
Inventory808644729794707760679
Other undisclosed current assets894994999999573790920
Total current assets:19,18716,46116,63219,92914,44615,17612,643
Noncurrent Assets
Operating lease, right-of-use asset633696756784169  
Property, plant and equipment27530232021095106110
Restricted cash and investments     7575
Total noncurrent assets:9089981,076994264181185
TOTAL ASSETS:20,09517,45917,70920,92314,71015,35712,828
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,9503,4212,9003,8922,8492,1221,689
Accounts payable723624612714180332498
Accrued liabilities623655716505615420261
Employee-related liabilities2,1892,0381,3192,4191,8431,251842
Other undisclosed accounts payable and accrued liabilities41410325325421011987
Deferred revenue0   371
Debt     78997
Derivative instruments and hedges, liabilities      1
Other undisclosed current liabilities33330232020418  
Total current liabilities:4,2833,7233,2204,0972,8702,2072,688
Noncurrent Liabilities
Long-term debt and lease obligation402474563644155  
Operating lease, liability402474563644155  
Liabilities, other than long-term debt11151151151201679
Deferred revenue1111119
Other liabilities 113113113118166 
Other undisclosed noncurrent liabilities      78
Total noncurrent liabilities:40358967875927516787
Total liabilities:4,6864,3123,8974,8563,1442,3742,775
Stockholders' equity
Stockholders' equity attributable to parent15,40913,14813,81116,06711,56512,98310,053
Common stock1111000
Treasury stock, value(6)(6)(6)(6)(6)(6)(6)
Additional paid in capital93,53888,49387,09186,72879,27478,98073,274
Accumulated other comprehensive loss(61)(11)(2)(4)(13)  
Accumulated deficit(78,062)(75,329)(73,272)(70,651)(67,690)(65,991)(63,215)
Total stockholders' equity:15,40913,14813,81116,06711,56512,98310,053
TOTAL LIABILITIES AND EQUITY:20,09517,45917,70920,92314,71015,35712,828

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues4,0324,3843,1042,3363,7901,927859
Cost of revenue(909)(1,110)(902)(623)(1,008)(855)(419)
Cost of goods and services sold   (113)(102)(84)(85)
Gross profit:3,1223,2742,2031,7132,7821,071440
Operating expenses(5,828)(5,304)(4,802)(4,646)(4,469)(3,616)(3,288)
Operating loss:(2,706)(2,030)(2,600)(2,932)(1,687)(2,545)(2,849)
Nonoperating income (expense)(5)(4)(6)(0)108(230)(437)
Investment income, nonoperating    123  
Other nonoperating expense(5)(4)(6)(0)(15)(230)(437)
Interest and debt expense    (232)(189)(348)
Loss from continuing operations before equity method investments, income taxes:(2,711)(2,034)(2,606)(2,933)(1,810)(2,965)(3,634)
Other undisclosed income (loss) from continuing operations before income taxes    (696)189348
Loss from continuing operations before income taxes:(2,711)(2,034)(2,606)(2,933)(2,507)(2,775)(3,286)
Income tax expense (benefit)(22)(23)(16)(28)2,583(1)(1)
Income (loss) before gain (loss) on sale of properties:(2,733)(2,057)(2,621)(2,961)76(2,777)(3,287)
Other undisclosed net loss    (1,775)  
Net loss attributable to parent:(2,733)(2,057)(2,621)(2,961)(1,698)(2,777)(3,287)
Other undisclosed net loss available to common stockholders, basic(640)      
Net loss available to common stockholders, diluted:(3,373)(2,057)(2,621)(2,961)(1,698)(2,777)(3,287)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(2,733)(2,057)(2,621)(2,961)(1,698)(2,777)(3,287)
Other comprehensive income (loss)(50)(8)28   
Other undisclosed comprehensive loss    (13)  
Comprehensive loss, net of tax, attributable to parent:(2,783)(2,065)(2,619)(2,952)(1,711)(2,777)(3,287)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: